PS
CLLS

Principal Securities’s Cellectis CLLS Stock Holding History

Principal Securities’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-179
Closed -$510 – 1722
2025
Q3 		$510 Hold
179
– – ﹤0.01% 3530
2025
Q2 		$273 Buy
179
+127
+244% +$184 ﹤0.01% 3574
2025
Q1 		$94 Hold
52
– – ﹤0.01% 3511
2024
Q4 		$94 Buy
+52
New +$97 ﹤0.01% 3506

Other funds holding CLLS

BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Principal Securities's CLLS Position: Q4 2025 in Review

Principal Securities sold out of Cellectis (CLLS) in Q4 2025, closing a stake of 179 shares — an estimated $510 sold.

Principal Securities first reported a position in CLLS in Q4 2024 and held it in 4 quarters. The position peaked at $510 in Q3 2025. 34 funds tracked by Wall St. Rank hold CLLS as of Q4 2025.

  • Principal Securities reported no remaining Cellectis position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 179 Cellectis shares in Q4 2025, an estimated $510.
  • Principal Securities first reported a position in Cellectis in Q4 2024 and held it in 4 quarters.
  • Principal Securities's Cellectis position peaked at $510 in Q3 2025.
  • 34 funds tracked by Wall St. Rank held Cellectis as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.